3Kirn DH, McCormick F. Replicating viruses as selective cancer therapeutics. Mol Med Today,1996; 2(12) : 519.
4Lorence RM, Rcichard KW, Katubig BB, et al.Complete regresson Of human neuroblastoma xenografts in athymic mice atfte local Newcasstle disease virus therapy. J Natl Caneer Inst, 1994; 86:1228.
5Mosmaan T. Colorimetric assay cellular growth and survival:Applicat ion to proliferation and cytotoxity assays. J Immunol Methods, 1983 ; 65 : 55.
6Reichard KW, Lorence RM, Cascino CJ, et al.Newcastle disease virus selectively kills human tumor cells. J Surg Res,1992:52(5) : 448.
7Csatary LK, Sandor E, Istran B,et al. Attenuated veterinary virus vaccine for the treatment of cancer. Cancer Detect Prev,1993:17(6) ; 619.
8Shannon K, Joseph SP. Virus as oncolytic agents: a new age for"therapeutic"viruses. J Natl Cancer Inst, 1994:86(16) : 1185.
9Lorence RM, Pamela AR, Keith WK. Newcastle disease virus as an antineoplastic agent : induction of tumor necrosis factor-α, and augmentation of its cytotoxicity. J Natl Cancer Inst, 1988 : 80 (16) : 1305.
10Csatary L, Gergely P. Vaccine therapy of malignant tumors. Orv Hetil,1990:131(47) : 2585.
二级参考文献1
1A. Adler,J. A. Stein,A. J. Goldfarb,E. Levy,M. Inbar,I. Altboim,R. R. Rozin,Z. Teva,B. Czernobilsky. Active, specific immunotherapy of stage III breast cancer[J] 1980,Cancer Immunology Immunotherapy(1):45～56
3Kirn DH, Mc-Cormick F. Replicating viruses as selective cancer therapeutics. Mol Med Today, 1996; 2(12) : 519
4Csatary LK,Eckhardt S, Bukosza I,et al. Attenuated veterinary vaccine for the treatment of cancer. Cancer Detect Prev,1993;17(6) : 617
5Lorence RM, Reichard KW, Katubig BB, et al.Complete regression of human neuroblastoma xenografts in athymic mice after local Newcastle disease virus therapy. J Natl Cancer Inst, 1994; 86(16) : 1228
6Kerr JF ,Winterford CM,Harmon BV. Apoptosis . Its singnificance in cancer and cancer therapy. Cancer ,1994;73(8): 2013
7Vaux DL , Cory S , Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature , 1988;29(335):440
8Muller M,Wilder S, Bannasch D,et al. p53 activates the CD95 (APO1/Fas) gene in response to DNA damage by anticancer drugs. J Exp Med, 1998; 188(11) : 2033
9Vignaux F , Golstein P. Fas-based lymphocytemediated cytotoxicity against syngeneic activated lymphocytes : a regulatory pathway. Eur J Immunol , 1994;24(4): 923
10Mapara MY, Bargou R, Zugck C, et al. APO-1mediated apoptosis or proliferation in human chronic B lymphocytic leukemia : correlation with bcl-2oncogene expression. Eur J Immunol, 1993; 23 (3):702
